Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…
Sheba Researchers Find Significant Improvements in Patient Safety Standard Following Deployment of MedAware’s Machine Learning-based Platform
Sheba Medical Center, Tel Hashomer, one of Israel’s leading medical centers, today announced the findings of research validating the…